HiberCell
PrivateLast Round
Series B
May 19, 2021
Total Funding Raised
$158.15M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
HiberCell is a biotechnology company that develops therapeutic agents targeting adaptive stress pathways and immune modulation to combat cancer treatment resistance, relapse, and metastasis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HiberCell Comparables
Compare HiberCell with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Oniria Therapeutics | 81% | |
| Bantam Pharmaceutical | 78% | |
| NMS Group | 74% |
HiberCell Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 19, 2021 | ||||
| Debt | May 19, 2021 | ||||
| Series A | Feb 7, 2019 |
HiberCell Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Magnetic Ventures | Series B |
| New York City Economic Development Corporation | Series A |
| Hercules Capital | Debt, Series B |
| Hillhouse Investment | Series A |
| ARCH Venture Partners | Series B, Series A |
| Magnetic Ventures | Series B |
| Trinitas Capital Management | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 48% MoM.
- Jul 25, 2026
Monthly visitors grew 199% MoM, reaching 1.6K.
HiberCell Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about HiberCell's valuation, stock price, and market status.
Is Hibercell a public or private company?
Hibercell is a private company.
What is the current stock price of Hibercell?
Hibercell is a private company with no public stock price. No recent secondary market data is available.
How much is Hibercell worth (valuation)?
Valuation information for Hibercell is not publicly available.
Can I buy Hibercell stock?
Hibercell shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Hibercell's last funding round?
Hibercell's most recent funding round was Debt on May 19, 2021.
Who are the main investors in Hibercell?
Key investors in Hibercell include Hercules Capital, Trinitas Capital Management, ARCH Venture Partners, Monashee Investment Management.
Will Hibercell IPO soon?
No public IPO plans have been announced for Hibercell.
How can I track Hibercell secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hibercell's secondary market activity and sign up for updates.